These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 26950455)
1. Pravastatin and C reactive protein modulate protease- activated receptor-1 expression in vitro blood platelets. Chu LX; Zhou SX; Yang F; Qin YQ; Liang ZS; Mo CG; Wang XD; Xie J; He LP Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):75-80. PubMed ID: 26950455 [TBL] [Abstract][Full Text] [Related]
2. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. Marwali MR; Hu CP; Mohandas B; Dandapat A; Deonikar P; Chen J; Cawich I; Sawamura T; Kavdia M; Mehta JL J Pharmacol Exp Ther; 2007 Sep; 322(3):1324-32. PubMed ID: 17538005 [TBL] [Abstract][Full Text] [Related]
3. A critical role of thrombin/PAR-1 in ADP-induced platelet secretion and the second wave of aggregation. Jiang L; Xu C; Yu S; Liu P; Luo D; Zhou Q; Gao C; Hu H J Thromb Haemost; 2013 May; 11(5):930-40. PubMed ID: 23406164 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. Ahn HS; Foster C; Boykow G; Stamford A; Manna M; Graziano M Biochem Pharmacol; 2000 Nov; 60(10):1425-34. PubMed ID: 11020444 [TBL] [Abstract][Full Text] [Related]
5. Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity Coexists With Platelet PAR (Protease-Activated Receptor)-1 and PAR-4-Mediated Thrombin Resistance. Gnanenthiran SR; Pennings GJ; Reddel CJ; Campbell H; Kockx M; Hamilton JR; Chen VM; Kritharides L Arterioscler Thromb Vasc Biol; 2022 Aug; 42(8):960-972. PubMed ID: 35708029 [TBL] [Abstract][Full Text] [Related]
6. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition. Badr Eslam R; Lang IM; Kaider A; Panzer S Transl Res; 2013 May; 161(5):414-20. PubMed ID: 23313628 [TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor-induced Akt activation--regulation and possible function. Reséndiz JC; Kroll MH; Lassila R J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. Wu CC; Teng CM Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935 [TBL] [Abstract][Full Text] [Related]
9. [Role of adenosine diphosphate in the course of thrombin signal transmission]. Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817 [TBL] [Abstract][Full Text] [Related]
10. Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study). Serebruany VL; Miller M; Pokov AN; Malinin AI; Lowry DR; Tanguay JF; Hennekens CH Am J Cardiol; 2006 May; 97(9):1332-6. PubMed ID: 16635606 [TBL] [Abstract][Full Text] [Related]
11. Thrombin-induced lysosomal exocytosis in human platelets is dependent on secondary activation by ADP and regulated by endothelial-derived substances. Södergren AL; Svensson Holm AC; Ramström S; Lindström EG; Grenegård M; Öllinger K Platelets; 2016; 27(1):86-92. PubMed ID: 25970449 [TBL] [Abstract][Full Text] [Related]
12. Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation. Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW Transl Res; 2013 May; 161(5):421-9. PubMed ID: 23340049 [TBL] [Abstract][Full Text] [Related]
13. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans. Wacker J; Lucchinetti E; Jamnicki M; Aguirre J; Härter L; Keel M; Zaugg M Anesth Analg; 2008 Jun; 106(6):1749-58. PubMed ID: 18499605 [TBL] [Abstract][Full Text] [Related]
14. Quantification of platelet function - a comparative study of venous and arterial blood using a novel flow cytometry protocol. Törnudd M; Rodwan Al Ghraoui M; Wahlgren S; Björkman E; Berg S; Kvitting JP; Alfredsson J; Ramström S Platelets; 2022 Aug; 33(6):926-934. PubMed ID: 35073813 [TBL] [Abstract][Full Text] [Related]
15. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease. Serebruany VL; Kogushi M; Dastros-Pitei D; Flather M; Bhatt DL Thromb Haemost; 2009 Jul; 102(1):111-9. PubMed ID: 19572075 [TBL] [Abstract][Full Text] [Related]
16. Amyloid beta peptide-activated signal pathways in human platelets. Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035 [TBL] [Abstract][Full Text] [Related]
17. Potentiation by adrenaline of agonist-induced responses in normal human platelets in vitro. Haaland HD; Holmsen H Platelets; 2011; 22(5):328-37. PubMed ID: 21388249 [TBL] [Abstract][Full Text] [Related]